Flamel Technologies (FLML+1.5%) bucks a weak tape today after saying it's signed a multi-year development partnership agreement with an undisclosed, large international pharmaceutical company. The development work, which will be done in Flamel's Bordeaux facility in France, is expected to generate revenue of over $4M over the next several years, and could be expanded.